(Q40390211)

20 September 2017

1 reference

title

Levofloxacin. A review of its antibacterial activity, pharmacokinetics and therapeutic efficacy (English)

1 reference

20 September 2017

1 reference

R Davis

1

1 reference

20 September 2017

H M Bryson

series ordinal

2

1 reference

20 September 2017

publication date

1 April 1994

1 reference

20 September 2017

1 reference

20 September 2017

volume

47

1 reference

20 September 2017

issue

4

1 reference

20 September 2017

page(s)

677-700

1 reference

Drug-drug interactions with fluoroquinolones.

20 September 2017

cites work

1 reference

12 December 2020

Pharmacokinetics of three newer quinolones in pregnant and lactating women

1 reference

12 December 2020

In vitro activity of DR-3355, an optically active ofloxacin

1 reference

12 December 2020

Comparative antibiotic susceptibilities of anaerobes associated with infections of the female reproductive tract.

1 reference

12 December 2020

Effect of staggered dose of calcium on the bioavailability of ciprofloxacin

1 reference

12 December 2020

Induction of resistance of Streptococcus pneumoniae to quinolones in vitro

1 reference

12 December 2020

In-vitro activity of DR-3355, an optically active isomer of ofloxacin, against bacterial pathogens associated with travellers' diarrhoea

1 reference

12 December 2020

Fluoroquinolones protect the human lymphocyte CEM cell line from HIV-1-mediated cytotoxicity

1 reference

12 December 2020

Phototoxic potential of quinolone antibacterial agents in Balb/c mice

1 reference

12 December 2020

Overview of drug interactions with the quinolones

1 reference

12 December 2020

Central nervous system toxicity of quinolones: human and animal findings

1 reference

12 December 2020

Bactericidal Activities of Ofloxacin and Its Optically Active Isomer (DR-3355) on Non-Growing Cells <i>of Escherichia coli </i>and <i>Pseudomonas aeruginosa</i>

1 reference

12 December 2020

Chemotherapy of biliary tract infections (XXXVII). Excretion into bile and gallbladder tissue levels of levofloxacin and its clinical effect in biliary tract infections

1 reference

12 December 2020

Inhibition by quinolones of DNA gyrase from Staphylococcus aureus

1 reference

12 December 2020

Enantioselective disposition of ofloxacin in humans

1 reference

12 December 2020

Clinical efficacy of levofloxacin (LVFX) single-dose therapy in female acute uncomplicated cystitis

1 reference

12 December 2020

The bactericidal activity of DR-3355, an optically active isomer of ofloxacin

1 reference

12 December 2020

Interaction of the new quinolone antibacterial agent levofloxacin with fenbufen in mice

1 reference

12 December 2020

In vitro activity of levofloxacin, ofloxacin and other quinolones against coagulase-negative staphylococci.

1 reference

12 December 2020

In vitro antibacterial activity of DR-3355, the S-(-)-isomer of ofloxacin.

1 reference

12 December 2020

The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro

1 reference

12 December 2020

Combined use of ciprofloxacin and sucralfate

1 reference

12 December 2020

Interactions of the 4-quinolones with other antibacterials.

1 reference

12 December 2020

Accumulation of a newly developed fluoroquinolone, OPC-17116, by human polymorphonuclear leukocytes

1 reference

12 December 2020

Mechanisms of Resistance to Quinolones

1 reference

12 December 2020

Sub-inhibitory and post-antibiotic effects of an optically active isomer of ofloxacin

1 reference

12 December 2020

Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use.

1 reference

12 December 2020

Potential mechanisms of resistance to the modern fluorinated 4-quinolones

1 reference

12 December 2020

Significance of the methyl group on the oxazine ring of ofloxacin derivatives in the inhibition of bacterial and mammalian type II topoisomerases

1 reference

12 December 2020

A study on the concentrations of levofloxacin in the gallbladder tissue and bile of patients

1 reference

12 December 2020

Fluoroquinolone antimicrobial agents

1 reference

12 December 2020

Inhibition of DNA gyrase by optically active ofloxacin

1 reference

12 December 2020

[Sputum penetration of levofloxacin and its clinical efficacy in patients with chronic lower respiratory tract infections]

1 reference

12 December 2020

Acute nongonococcal epididymitis--pharmacological and therapeutic aspects of levofloxacin

1 reference

12 December 2020

Bactericidal activity of enoxacin and lomefloxacin against Escherichia coli KL16.

1 reference

12 December 2020

In vitro and in vivo antibacterial activities of E-4497, a new 3-amine-3-methyl-azetidinyl tricyclic fluoroquinolone

1 reference

12 December 2020

The mode of action of quinolones: The paradox in activity of low and high concentrations and activity in the anaerobic environment

1 reference

12 December 2020

Quinolone antimicrobial agents and theophylline

1 reference

12 December 2020

Synergy and antagonism of combinations with quinolones

1 reference

12 December 2020

Levofloxacin disk potency and tentative interpretive criteria for susceptibility tests

1 reference

12 December 2020

Do we need an intravenous fluoroquinolone?

1 reference

12 December 2020

Antibacterial activity of fluoroquinolones in combination with zidovudine

1 reference

12 December 2020

The effect of sucralfate pretreatment on the pharmacokinetics of ciprofloxacin

1 reference

12 December 2020

Quinolone antibacterial-agent-induced cutaneous phototoxicity: ear swelling reactions in Balb/c mice.

1 reference

12 December 2020

The post-antimicrobial suppressive effect of quinolone agents.

1 reference

12 December 2020

Effects of aluminum and magnesium antacids and ranitidine on the absorption of ciprofloxacin

1 reference

12 December 2020

Elimination of antibiotic-resistant plasmids by quinolone antibiotics.

1 reference

12 December 2020

The Epidemiology of Bacterial Resistance to Quinolones

1 reference

12 December 2020

In-vitro and in-vivo activity of DR-3355, an optically active isomer of ofloxacin

1 reference

12 December 2020

Effect of quinolones on human neutrophil chemotaxis

1 reference

12 December 2020

The effect of levofloxacin, an optically-active isomer of ofloxacin, on fecal microflora in human volunteers

1 reference

12 December 2020

Effects of antacids, ferrous sulfate, and ranitidine on absorption of DR-3355 in humans

1 reference

12 December 2020

Inhibitory effects of quinolones on DNA gyrase of Escherichia coli and topoisomerase II of fetal calf thymus

1 reference

12 December 2020

Phototoxic potential of the new quinolone antibacterial agent levofloxacin in mice

1 reference

12 December 2020

Involvement of inhibitory and excitatory neurotransmitters in levofloxacin- and ciprofloxacin-induced convulsions in mice

1 reference

12 December 2020

The Use of Quinolones in Developing Countries

1 reference

12 December 2020

Fluoroquinolone antimicrobial agents

1 reference

12 December 2020

Synergy of levofloxacin (L-ofloxacin) and oxacillin against quinolone-resistant Staphylococcus aureus, measured by the time-kill method

1 reference

12 December 2020

Uptake and intracellular activity of an optically active ofloxacin isomer in human neutrophils and tissue culture cells

1 reference

12 December 2020

Laboratory survey of fluoroquinolone activity

1 reference

12 December 2020

In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacin

1 reference

12 December 2020

Mechanistic aspects of DNA topoisomerases.

1 reference

12 December 2020

Effects of magnesium-aluminum hydroxide and calcium carbonate antacids on bioavailability of ofloxacin

1 reference

12 December 2020

In vitro antimicrobial activity of DR-3355, a new quinolone antibacterial agent, against clinical isolates of enteritis-causing bacteria

1 reference

12 December 2020

Inhibition of Legionella pneumophila in guinea pig peritoneal macrophages by new quinolone, macrolide and other antimicrobial agents.

1 reference

12 December 2020

Impact of the fluoroquinolones on gastrointestinal flora.

1 reference

12 December 2020

Pharmacokinetics of ofloxacin after parenteral and oral administration

1 reference

12 December 2020

Comparative in vitro and in vivo activities of six new monofluoroquinolone and difluoroquinolone 3-carboxylic acids with a 7-azetidin ring substituent

1 reference

12 December 2020

The postantibiotic suppressive effect of L-ofloxacin, an optically active isomer of ofloxacin.

1 reference

12 December 2020

Quinolones in urology

1 reference

12 December 2020

Inhibition of plasmid conjugation by some recently synthetized 4-quinolone compounds

1 reference

12 December 2020

Inhibition of norfloxacin absorption by antacids

1 reference

12 December 2020

The fluoroquinolones exert a reduced rate of kill against Enterococcus faecalis

1 reference

12 December 2020

Twenty-six-week oral toxicity of the new quinolone antibacterial agent levofloxacin in rats and cynomolgus monkeys

1 reference

12 December 2020

10.2165/00003495-199447040-00008

Identifiers

DOI

1 reference

Dimensions Publication ID

20 September 2017

1013068157

0 references

1 reference